Erdheim-Chester disease

被引:17
作者
Haroche, J. [1 ]
Cohen-Aubart, F. [1 ]
Arnaud, L. [1 ]
Hervier, B. [1 ]
Charlotte, F. [2 ]
Drier, A. [3 ]
Gorochov, G. [4 ]
Grenier, P. A. [5 ]
Cluzel, P.
Maksud, P. [6 ]
Emile, J. -F. [7 ]
Amoura, Z. [1 ]
机构
[1] Univ Paris 06, Grp Hosp Pitie Salpetriere, AP HP, Ctr Natl Reference Malad Syst Rares,Serv Med Inte, F-75651 Paris, France
[2] Univ Paris 06, Grp Hosp Pitie Salpetriere, AP HP, Serv Anatomopathol, F-75651 Paris, France
[3] Univ Paris 06, Grp Hosp Pitie Salpetriere, AP HP, Serv Neuroradiol, F-75651 Paris, France
[4] INSERM, UMR S 945, Paris, France
[5] Univ Paris 06, Grp Hosp Pitie Salpetriere, AP HP, Serv Radiol, F-75651 Paris, France
[6] Univ Paris 06, Grp Hosp Pitie Salpetriere, AP HP, Serv Med Nucl, F-75651 Paris, France
[7] Univ St Quentin en Yvelines, AP HP, Dept Anatomopathol, EA4340, F-92100 Boulogne, France
来源
REVUE DE MEDECINE INTERNE | 2014年 / 35卷 / 11期
关键词
Erdheim-Chester disease; Histiocytosis; BRAF; Interferon-alpha; LANGERHANS-CELL HISTIOCYTOSIS; IMATINIB MESYLATE; INTERFERON-ALPHA; BRAF MUTATIONS; INVOLVEMENT; MANIFESTATIONS; VEMURAFENIB; DIAGNOSIS; EFFICACY; PATIENT;
D O I
10.1016/j.revmed.2014.04.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Erdheim-Chester disease is a rare and orphan disease. Despite having been overlooked previously, numerous new cases have been diagnosed more recently. The number of Erdheim-Chester disease cases reported has increased substantially: more than 300 new cases have been published in the past 10 years. This situation is mainly a result of the generally better awareness among pathologists, radiologists, and clinicians of various aspects of this rare disease. The field has been particularly active in the last few years, with evidence of the efficacy of interferon-a, the description of a systemic pro-inflammatory cytokine signature, and most recently, reports of the dramatic efficacy of BRAF inhibition in severe, BRAF(V600E) mutation-associated cases of Erdheim-Chester disease. Also, BRAF mutations have been found in more than half of the patients with Erdheim-Chester disease who were tested. Detailed elucidation of the pathogenesis of the disease is likely to lead to the development of better targeted and more effective therapies. (C) 2014 Societe nationale francaise de medecine interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:715 / 722
页数:8
相关论文
共 58 条
[1]  
Adam Z, 2011, Vnitr Lek, V57, P576
[2]  
Alper M G, 1983, Trans Am Ophthalmol Soc, V81, P64
[3]   Two enlarged kidneys:: A manifestation of Erdheim-Chester disease [J].
André, M ;
Delèvaux, I ;
de Fraissinette, B ;
Ponsonnaille, J ;
Chalret, NC ;
Wechsler, B ;
Piette, JC ;
Aumaître, O .
AMERICAN JOURNAL OF NEPHROLOGY, 2001, 21 (04) :315-317
[4]   Rationale and efficacy of interleukin-1 targeting in Erdheim-Chester disease [J].
Aouba, Achille ;
Georgin-Lavialle, Sophie ;
Pagnoux, Christian ;
Silva, Nicolas Martin ;
Renand, Amedee ;
Galateau-Salle, Francoise ;
Le Toquin, Sophie ;
Bensadoun, Henri ;
Larousserie, Frederique ;
Silvera, Stephane ;
Provost, Nicole ;
Candon, Sophie ;
Seror, Raphaele ;
de Menthon, Mathilde ;
Hermine, Olivier ;
Guillevin, Loic ;
Bienvenu, Boris .
BLOOD, 2010, 116 (20) :4070-4076
[5]   CNS involvement and treatment with interferon-α are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients [J].
Arnaud, Laurent ;
Hervier, Baptiste ;
Neel, Antoine ;
Hamidou, Mohamed A. ;
Kahn, Jean-Emmanuel ;
Wechsler, Bertrand ;
Perez-Pastor, Gemma ;
Blomberg, Bjorn ;
Fuzibet, Jean-Gabriel ;
Dubourguet, Francois ;
Marinho, Antonio ;
Magnette, Catherine ;
Noel, Violaine ;
Pavic, Michel ;
Casper, Jochen ;
Beucher, Anne-Berangere ;
Costedoat-Chalumeau, Nathalie ;
Aaron, Laurent ;
Salvatierra, Juan ;
Graux, Carlos ;
Cacoub, Patrice ;
Delcey, Veronique ;
Dechant, Claudia ;
Bindi, Pascal ;
Herbaut, Christiane ;
Graziani, Giorgio ;
Amoura, Zahir ;
Haroche, Julien .
BLOOD, 2011, 117 (10) :2778-2782
[6]   Systemic perturbation of cytokine and chemokine networks in Erdheim-Chester disease: a single-center series of 37 patients [J].
Arnaud, Laurent ;
Gorochov, Guy ;
Charlotte, Frederic ;
Lvovschi, Virginie ;
Parizot, Christophe ;
Larsen, Martin ;
Ghillani-Dalbin, Pascale ;
Hervier, Baptiste ;
Kahn, Jean-Emmanuel ;
Deback, Claire ;
Musset, Lucile ;
Amoura, Zahir ;
Haroche, Julien .
BLOOD, 2011, 117 (10) :2783-2790
[7]   Pulmonary Involvement in Erdheim-Chester Disease A single-center study of thirty-four patients and a review of the literature [J].
Arnaud, Laurent ;
Pierre, Isabelle ;
Beigelman-Aubry, Catherine ;
Capron, Frederique ;
Brun, Anne-Laure ;
Rigolet, Aude ;
Girerd, Xavier ;
Weber, Nina ;
Piette, Jean-Charles ;
Grenier, Philippe A. ;
Amoura, Zahir ;
Haroche, Julien .
ARTHRITIS AND RHEUMATISM, 2010, 62 (11) :3504-3512
[8]   18F-Fluorodeoxyglucose-Positron Emission Tomography Scanning Is More Useful in Followup Than in the Initial Assessment of Patients With Erdheim-Chester Disease [J].
Arnaud, Laurent ;
Malek, Zoulikha ;
Archambaud, Frederique ;
Kas, Aurelie ;
Toledano, Dan ;
Drier, Aurelie ;
Zeitoun, Delphine ;
Cluzel, Philippe ;
Grenier, Philippe A. ;
Chiras, Jacques ;
Piette, Jean-Charles ;
Amoura, Zahir ;
Haroche, Julien .
ARTHRITIS AND RHEUMATISM, 2009, 60 (10) :3128-3138
[9]   Recurrent BRAF mutations in Langerhans cell histiocytosis [J].
Badalian-Very, Gayane ;
Vergilio, Jo-Anne ;
Degar, Barbara A. ;
MacConaill, Laura E. ;
Brandner, Barbara ;
Calicchio, Monica L. ;
Kuo, Frank C. ;
Ligon, Azra H. ;
Stevenson, Kristen E. ;
Kehoe, Sarah M. ;
Garraway, Levi A. ;
Hahn, William C. ;
Meyerson, Matthew ;
Fleming, Mark D. ;
Rollins, Barrett J. .
BLOOD, 2010, 116 (11) :1919-1923
[10]   Scintigraphic Diagnosis of Erdheim-Chester Disease [J].
Balink, Hans ;
Hemmelder, Marc H. ;
de Graaf, Wout ;
Grond, Joris .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (16) :E470-E472